»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
°æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀº 2024-2029³â 26¾ï 6,600¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 5.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ °æÇÇÀû ¾à¹° Àü´Þ(Transdermal Drug Delivery) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê, °æÇÇ¿ë ÆÐÄ¡ Àû¿ë È®´ë, °æÇÇ ¾à¹° Àü´ÞÀ» À§ÇÑ »ýºÐÇØ¼º ¹× »ýüÀûÇÕ¼º ¼ÒÀç µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
4.6%
CAGR
5.1%
Áõ°¡¾×
26¾ï 6,600¸¸ ´Þ·¯
º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
º» Á¶»ç´Â ÇâÈÄ ¸î ³â µ¿¾È °æÇÇ ¾à¹° Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î °æÇÇÈí¼öÇü ÀǾàǰ¿¡ ´ëÇÑ °ü½É Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ È°¹ßÇÑ ¼ö¿ä¿Í »ç¾÷ È®ÀåÀ» À§ÇÑ °øµ¿¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2024³â)
½ÃÀå Àü¸Á(2024-2029³â)
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀå(2019-2023³â)
¿ëµµº° ºÎ¹® ºÐ¼®(2019-2023³â)
À¯Çüº° ºÎ¹® ºÐ¼®(2019-2023³â)
±â¼úº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ°æÇÇ ¾à¹°Àü´Þ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
ÁøÅëÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½Å°æ Áúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
È£¸£¸ó ´ëü¿ä¹ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÉÇ÷°ü Áúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¿ëµµº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
°æÇÇ ÆÐÄ¡ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
°æÇÇ Èí¼öÇü ¹Ý°íÇüÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Çüº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ±â¼úº°
½ÃÀå ºÎ¹®
ºñ±³ : ±â¼úº°
Microneedles : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Iontophoresis : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Sonophoresis : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Electroporation : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ±â¼úº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¸ß½ÃÄÚ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
ÆÄ±«Àû Çõ½Å »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Boehringer Ingelheim International GmbH
Croda International Plc
Hisamitsu Pharmaceutical Co. Inc.
Johnson and Johnson Services Inc.
Kindeva Drug Delivery L.P.
Luye Pharma Group Ltd.
Medherant Ltd.
Novartis AG
ProSolus Inc.
Purdue Pharma LP
Sparsha Pharma International Pvt. Ltd.
Teikoku Seiyaku Co. Ltd.
UCB SA
Viatris Inc.
Á¦16Àå ºÎ·Ï
LSH
The transdermal drug delivery market is forecasted to grow by USD 2,666 mn during 2024-2029, accelerating at a CAGR of 5.1% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 4.6%
CAGR 5.1%
Incremental Value $2,666 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's transdermal drug delivery market is segmented as below:
By Application
Analgesics
Neurological disorders
Hormone replacement therapy
Cardiovascular disorders
Others
By Type
Transdermal patches
Transdermal semisolids
By Technology
Microneedles
Iontophoresis
Sonophoresis
Electroporation
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.
The report on the transdermal drug delivery market covers the following areas:
Transdermal Drug Delivery Market sizing
Transdermal Drug Delivery Market forecast
Transdermal Drug Delivery Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson Services Inc., Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Transdermal Drug Delivery Market 2019 - 2023
Historic Market Size - Data Table on Global Transdermal Drug Delivery Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in the global transdermal drug delivery market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Analgesics - Market size and forecast 2024-2029
Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
8.4 Neurological disorders - Market size and forecast 2024-2029
Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
8.5 Hormone replacement therapy - Market size and forecast 2024-2029
Chart on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Chart on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Data Table on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
8.6 Cardiovascular disorders - Market size and forecast 2024-2029
Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Transdermal patches - Market size and forecast 2024-2029
Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
9.4 Transdermal semisolids - Market size and forecast 2024-2029
Chart on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Technology
10.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
10.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
10.3 Microneedles - Market size and forecast 2024-2029
Chart on Microneedles - Market size and forecast 2024-2029 ($ million)
Data Table on Microneedles - Market size and forecast 2024-2029 ($ million)
Chart on Microneedles - Year-over-year growth 2024-2029 (%)
Data Table on Microneedles - Year-over-year growth 2024-2029 (%)
10.4 Iontophoresis - Market size and forecast 2024-2029
Chart on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Data Table on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Chart on Iontophoresis - Year-over-year growth 2024-2029 (%)
Data Table on Iontophoresis - Year-over-year growth 2024-2029 (%)
10.5 Sonophoresis - Market size and forecast 2024-2029
Chart on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Data Table on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Chart on Sonophoresis - Year-over-year growth 2024-2029 (%)
Data Table on Sonophoresis - Year-over-year growth 2024-2029 (%)
10.6 Electroporation - Market size and forecast 2024-2029
Chart on Electroporation - Market size and forecast 2024-2029 ($ million)
Data Table on Electroporation - Market size and forecast 2024-2029 ($ million)
Chart on Electroporation - Year-over-year growth 2024-2029 (%)
Data Table on Electroporation - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
3M Co.
3M Co. - Overview
3M Co. - Business segments
3M Co. - Key news
3M Co. - Key offerings
3M Co. - Segment focus
SWOT
15.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.6 Croda International Plc
Croda International Plc - Overview
Croda International Plc - Business segments
Croda International Plc - Key offerings
Croda International Plc - Segment focus
SWOT
15.7 Hisamitsu Pharmaceutical Co. Inc.
Hisamitsu Pharmaceutical Co. Inc. - Overview
Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Hisamitsu Pharmaceutical Co. Inc. - Key offerings
SWOT
15.8 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.9 Kindeva Drug Delivery L.P.
Kindeva Drug Delivery L.P. - Overview
Kindeva Drug Delivery L.P. - Product / Service
Kindeva Drug Delivery L.P. - Key offerings
SWOT
15.10 Luye Pharma Group Ltd.
Luye Pharma Group Ltd. - Overview
Luye Pharma Group Ltd. - Business segments
Luye Pharma Group Ltd. - Key offerings
Luye Pharma Group Ltd. - Segment focus
SWOT
15.11 Medherant Ltd.
Medherant Ltd. - Overview
Medherant Ltd. - Product / Service
Medherant Ltd. - Key offerings
SWOT
15.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.13 ProSolus Inc.
ProSolus Inc. - Overview
ProSolus Inc. - Product / Service
ProSolus Inc. - Key offerings
SWOT
15.14 Purdue Pharma LP
Purdue Pharma LP - Overview
Purdue Pharma LP - Product / Service
Purdue Pharma LP - Key offerings
SWOT
15.15 Sparsha Pharma International Pvt. Ltd.
Sparsha Pharma International Pvt. Ltd. - Overview
Sparsha Pharma International Pvt. Ltd. - Product / Service
Sparsha Pharma International Pvt. Ltd. - Key offerings
SWOT
15.16 Teikoku Seiyaku Co. Ltd.
Teikoku Seiyaku Co. Ltd. - Overview
Teikoku Seiyaku Co. Ltd. - Product / Service
Teikoku Seiyaku Co. Ltd. - Key offerings
SWOT
15.17 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations